# Ophelia

- Link: https://100xfounder.com/startup/ophelia/
- Published: 2024-01-01T00:00:00+05:30
- Author: Ishaan Vardhan

Ophelia is a US telehealth company that treats opioid addiction from home. Patients
meet a licensed clinician by video and, if eligible, are prescribed buprenorphine(
best known by the brand name Suboxone), a medication that eases cravings and withdrawal.
Ophelia calls this medication-assisted treatment. HIT Consultant reported that its
care model adapts the Massachusetts Collaborative Care Model to telemedicine, pairing
each patient with a team that includes a prescribing clinician, a nurse and a care
coordinator.

Ophelia’s pricing page says its self-pay plan costs $245 a month and covers all 
clinician video calls, Suboxone medication management if eligible, seven-day-a-week
support from the care team, comfort medication for withdrawal symptoms, and treatment
of depression, anxiety and insomnia. Ophelia is in network with many insurers, including
Medicaid, Medicare, Cigna, Humana, Blue Cross Blue Shield plans, Anthem and UnitedHealthcare,
depending on state. When we checked, it listed care as available in California, 
Connecticut, Delaware, Florida, Maine, Maryland, Montana, New Jersey, New York, 
Pennsylvania, Texas, Vermont, Virginia and Washington.

The company is based in New York City and was co-founded by CEO Zack Gray. In December
2021 it raised a $50 million Series B led by Tiger Global, with Menlo Ventures, 
General Catalyst, Refactor Capital and others, seven months after a $15 million 
Series A, for total funding of $68 million, HIT Consultant reported. In 2023 Ophelia
published a study in The American Journal of Drug and Alcohol Abuse of 1,378 patients
in New York and Pennsylvania, which found 56.4% were still in treatment after 180
days; this is the company’s own research.

_This page is research, not medical advice or a review. If you or someone you know
is struggling with opioid use, talk to a doctor or call the SAMHSA National Helpline
at 1-800-662-4357 in the US._